Genital human papillomavirus infection in men

Lancet Infectious Diseases

Volumn 6, Issue 1, 2006, Pages 21-31

  Partridge, Jeffrey M ^a   Koutsky, Laura A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

AGE DISTRIBUTION; ANTIBODY RESPONSE; CANCER; CLINICAL TRIAL; CONDYLOMA; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNIZATION; IMMUNOGENICITY; INCIDENCE; INFECTION PREVENTION; MALE GENITAL TRACT INFECTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SEROPREVALENCE; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYMPTOM; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; VIRUS PARTICLE; VIRUS STRAIN; WART VIRUS;

CONDYLOMATA ACUMINATA; GENITAL DISEASES, MALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SEROEPIDEMIOLOGIC STUDIES; SEXUALLY TRANSMITTED DISEASES, VIRAL; TIME FACTORS;

EID: 29244476850     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(05)70323-6     Document Type: Review

References (151)

1. GY Ho, R Bierman, L Beardsley, CJ Chang, RD Burk Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 1998 423 428
2. FX Bosch, MM Manos, N Munoz Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group J Natl Cancer Inst 87 1995 796 802
3. LA Koutsky, KK Holmes, CW Critchlow A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection N Engl J Med 327 1992 1272 1278
4. RL Winer, SK Lee, JP Hughes, DE Adam, NB Kiviat, LA Koutsky Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students Am J Epidemiol 157 2003 218 226
5. AB Moscicki, N Hills, S Shiboski Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females JAMA 285 2001 2995 3002
6. CB Woodman, S Collins, H Winter Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study Lancet 357 2001 1831 1836
7. N Munoz, FX Bosch, S de Sanjose Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 2003 518 527
8. LL Villa, RL Costa, CA Petta Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncol 6 2005 271 278
9. LA Koutsky, KA Ault, CM Wheeler A controlled trial of a human papillomavirus type 16 vaccine N Engl J Med 347 2002 1645 1651
10. DR Brown, KH Fife, CM Wheeler Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine Vaccine 22 2004 2936 2942
11. DM Harper, EL Franco, C Wheeler Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial Lancet 364 2004 1757 1765
12. JF Siegel, BC Mellinger Human papillomavirus in the male patient Urol Clin North Am 19 1992 83 91
13. ML Gillison, KV Shah Chapter 9: Role of mucosal human papillomavirus in nongenital cancers J Natl Cancer Inst Monogr 31 2003 57 65
14. LA Koutsky, DA Galloway, KK Holmes Epidemiology of genital human papillomavirus infection Epidemiol Rev 10 1988 122 163
15. DR Brown, JM Schroeder, JT Bryan, MH Stoler, KH Fife Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients J Clin Microbiol 37 1999 3316 3322
16. N Coleman, HD Birley, AM Renton Immunological events in regressing genital warts Am J Clin Pathol 102 1994 768 774
17. CE Greer, CM Wheeler, MB Ladner Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts J Clin Microbiol 33 1995 2058 2063
18. 2 laser and microwave Int J Dermatol 34 1995 209 211
19. LS Cook, LA Koutsky, KK Holmes Clinical presentation of genital warts among circumcised and uncircumcised heterosexual men attending an urban STD clinic Genitourin Med 69 1993 262 264
20. I Simms, CK Fairley Epidemiology of genital warts in England and Wales: 1971 to 1994 Genitourin Med 73 1997 365 367
21. TY Chuang, HO Perry, LT Kurland, DM Ilstrup Condyloma acuminatum in Rochester, Minn., 1950-1978. I. Epidemiology and clinical features Arch Dermatol 120 1984 469 475
22. G Persson, K Andersson, I Krantz Symptomatic genital papillomavirus infection in a community. Incidence and clinical picture Acta Obstet Gynecol Scand 75 1996 287 290
23. S Majewski, S Jablonska Human papillomavirus-associated tumors of the skin and mucosa J Am Acad Dermatol 36 1997 659 685 quiz 686-88
24. BJ Wiatrak Overview of recurrent respiratory papillomatosis Curr Opin Otolaryngol Head Neck Surg 11 2003 433 441
25. MJ Silverberg, P Thorsen, H Lindeberg, LA Grant, KV Shah Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis Obstet Gynecol 101 2003 645 652
26. BD Fredericks, A Balkin, HW Daniel, J Schonrock, B Ward, IH Frazer Transmission of human papillomaviruses from mother to child Aust N Z J Obstet Gynaecol 33 1993 30 32
27. F Pakarian, J Kaye, J Cason Cancer associated human papillomaviruses: perinatal transmission and persistence Br J Obstet Gynaecol 101 1994 514 517
28. EM Smith, SR Johnson, T Cripe Perinatal transmission and maternal risks of human papillomavirus infection Cancer Detect Prev 19 1995 196 205
29. M Puranen, M Yliskoski, S Saarikoski, K Syrjanen, S Syrjanen Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood Am J Obstet Gynecol 174 1996 694 699
30. J Cason, JN Kaye, RJ Jewers Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants J Med Virol 47 1995 209 218
31. DH Watts, LA Koutsky, KK Holmes Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study Am J Obstet Gynecol 178 1998 365 373
32. EM Smith, JM Ritchie, J Yankowitz Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission Sex Transm Dis 31 2004 57 62
33. CC Pao, PL Tsai, YL Chang, TT Hsieh, JY Jin Possible non-sexual transmission of genital human papillomavirus infections in young women Eur J Clin Microbiol Infect Dis 12 1993 221 222
34. SK Tay, TH Ho, SK Lim-Tan Is genital human papillomavirus infection always sexually transmitted? Aust N Z J Obstet Gynaecol 30 1990 240 242
35. C Sonnex, S Strauss, JJ Gray Detection of human papillomavirus DNA on the fingers of patients with genital warts Sex Transm Infect 75 1999 317 319
36. JJ Carter, MM Madeleine, K Shera Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites Cancer Res 61 2001 1934 1940
37. MR Cupp, RS Malek, JR Goellner, TF Smith, MJ Espy The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis J Urol 154 1995 1024 1029
38. J Dillner, G von Krogh, S Horenblas, CJ Meijer Etiology of squamous cell carcinoma of the penis Scand J Urol Nephrol Suppl 205 2000 189 193
39. MA Rubin, B Kleter, M Zhou Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis Am J Pathol 159 2001 1211 1218
40. JR Daling, MM Madeleine, LG Johnson Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease Int J Cancer 116 2005 606 616
41. HD Strickler, MH Schiffman, KV Shah A survey of human papillomavirus 16 antibodies in patients with epithelial cancers Eur J Cancer Prev 7 1998 305 313
42. DM Parkin, SL Whelen, J Ferlay, H Storm Cancer incidence in five continents vol. I to VIII 2005 International Agency for Research on Cancer Lyon IARC CancerBase 7
43. GS Gerber Carcinoma in situ of the penis J Urol 151 1994 829 833
44. M Melbye, M Frisch The role of human papillomaviruses in anogenital cancers Semin Cancer Biol 8 1998 307 313
45. M Frisch, B Glimelius, AJ van den Brule Sexually transmitted infection as a cause of anal cancer N Engl J Med 337 1997 1350 1358
46. M Frisch On the etiology of anal squamous carcinoma Dan Med Bull 49 2002 194 209
47. GR Williams, QL Lu, SB Love, IC Talbot, JM Northover Properties of HPV-positive and HPV-negative anal carcinomas J Pathol 180 1996 378 382
48. JR Daling, MM Madeleine, LG Johnson Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer Cancer 101 2004 270 280
49. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov ) SEER*Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2003 Sub (1973-2001). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004, based on the November 2003 submission.
50. MA Clark, A Hartley, JI Geh Cancer of the anal canal Lancet Oncol 5 2004 149 157
51. M Frisch, C Fenger, AJ van den Brule Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses Cancer Res 59 1999 753 757
52. M Schiffman, SK Kjaer Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia J Natl Cancer Inst Monogr 31 2003 14 19
53. PV Chin-Hong, E Vittinghoff, RD Cranston Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE Study J Infect Dis 190 2004 2070 2076
54. JR Daling, NS Weiss, TG Hislop Sexual practices, sexually transmitted diseases, and the incidence of anal cancer N Engl J Med 317 1987 973 977
55. F Saad, K Gu, J Jean-Baptiste, J Gauthier, AM MesMasson Absence of human papillomavirus sequences in early stage prostate cancer Can J Urol 6 1999 834 838
56. TR Griffiths, JK Mellon Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancer BJU Int 85 2000 211 217
57. T Noda, T Sasagawa, Y Dong, H Fuse, M Namiki, M Inoue Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method Urol Res 26 1998 165 169
58. HD Strickler, R Burk, K Shah A multifaceted study of human papillomavirus and prostate carcinoma Cancer 82 1998 1118 1125
59. M Kuczyk, J Serth, S Machtens, U Jonas Detection of viral HPV 16 DNA in prostate cancer and benign prostatic hyperplasia by quantitative PCR-directed analysis Prostate Cancer Prostatic Dis 3 suppl 1 2000 S23
60. J Serth, F Panitz, U Paeslack, MA Kuczyk, U Jonas Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers Cancer Res 59 1999 823 825
61. BM Steinberg, TP DiLorenzo A possible role for human papillomaviruses in head and neck cancer Cancer Metastasis Rev 15 1996 91 112
62. ML Gillison, WM Koch, RB Capone Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
63. VM van Houten, PJ Snijders, MW van den Brekel Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas Int J Cancer 93 2001 232 235
64. SM Schwartz, JR Daling, DR Doody Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection J Natl Cancer Inst 90 1998 1626 1636
65. RG McKaig, RS Baric, AF Olshan Human papillomavirus and head and neck cancer: epidemiology and molecular biology Head Neck 20 1998 250 265
66. ML Gillison, DR Lowy A causal role for human papillomavirus in head and neck cancer Lancet 363 2004 1488 1489
67. ML Gillison, KV Shah Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers Curr Opin Oncol 13 2001 183 188
68. JP Klussmann, S Dinh, O Guntinas-Lichius HPV-associated tonsillar cancer. An update HNO 52 2004 208 218 in German
69. R Herrero Chapter 7: Human papillomavirus and cancer of the upper aerodigestive tract J Natl Cancer Inst Monogr 31 2003 47 51
70. WJ Koskinen, RW Chen, I Leivo Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck Int J Cancer 107 2003 401 406
71. EM Smith, JM Ritchie, KF Summersgill Human papillomavirus in oral exfoliated cells and risk of head and neck cancer J Natl Cancer Inst 96 2004 449 455
72. S Syrjanen Human papillomavirus (HPV) in head and neck cancer J Clin Virol 32 suppl 1 2005 S59 S66
73. C Mao, JP Hughes, N Kiviat Clinical findings among young women with genital human papillomavirus infection Am J Obstet Gynecol 188 2003 677 684
74. W Prendiville P Davies The health professional's HPV handbook. Volume 1: human papillomavirus and cervical cancer 2004 Taylor & Francis London
75. A Strand, E Rylander, E Wilander, I Zehbe, W Kraaz Histopathologic examination of penile epithelial lesions is of limited diagnostic value in human papillomavirus infection Sex Transm Dis 23 1996 293 298
76. HB Krebs, V Schneider Human papillomavirus-associated lesions of the penis: colposcopy, cytology, and histology Obstet Gynecol 70 1987 299 304
77. J Dillner The serological response to papillomaviruses Semin Cancer Biol 9 1999 423 430
78. JJ Carter, LA Koutsky, JP Hughes Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection J Infect Dis 181 2000 1911 1919
79. A Molijn, B Kleter, W Quint, LJ van Doorn Molecular diagnosis of human papillomavirus (HPV) infections J Clin Virol 32 suppl 1 2005 S43 S51
80. CL Peyton, M Schiffman, AT Lorincz Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies J Clin Microbiol 36 1998 3248 3254
81. DC Swan, RA Tucker, G Tortolero-Luna Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type J Clin Microbiol 37 1999 1030 1034
82. PE Gravitt, CL Peyton, TQ Alessi Improved amplification of genital human papillomaviruses J Clin Microbiol 38 2000 357 361
83. B Kleter, LJ van Doorn, L Schrauwen Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus J Clin Microbiol 37 1999 2508 2517
84. PE Gravitt, MD Viscidi Measurement of exposure to human papillomaviruses TE Rohan KV Shah Cervical cancer: from etiology to prevention 2004 Kluwer Academic Publishers Dordrecht 119 141
85. M Hippelainen, S Syrjanen, H Koskela, J Pulkkinen, S Saarikoski, K Syrjanen Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts Sex Transm Dis 20 1993 321 328
86. WJ Melchers, R Schift, E Stolz, J Lindeman, WG Quint Human papillomavirus detection in urine samples from male patients by the polymerase chain reaction J Clin Microbiol 27 1989 1711 1714
87. G Astori, C Pipan, G Muffato, GA Botta Detection of HPV-DNA in semen, urine and urethral samples by dot blot and PCR New Microbiol 18 1995 143 149
88. PM Katelaris, YE Cossart, BR Rose Human papillomavirus: the untreated male reservoir J Urol 140 1988 300 305
89. BA Weaver, Q Feng, KK Holmes Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men J Infect Dis 189 2004 677 685
90. E Lazcano-Ponce, R Herrero, N Munoz High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples Sex Transm Dis 28 2001 277 280
91. CD Golijow, LO Perez, JS Smith, MC Abba Human papillomavirus DNA detection and typing in male urine samples from a high-risk population from Argentina J Virol Methods 124 2005 217 220
92. RS Ostrow, KR Zachow, M Niimura Detection of papillomavirus DNA in human semen Science 231 1986 731 733
93. O Olatunbosun, H Deneer, R Pierson Human papillomavirus DNA detection in sperm using polymerase chain reaction Obstet Gynecol 97 2001 357 360
94. YM Lai, FP Yang, CC Pao Human papillomavirus deoxyribonucleic acid and ribonucleic acid in seminal plasma and sperm cells Fertil Steril 65 1996 1026 1030
95. S Kyo, M Inoue, M Koyama, M Fujita, O Tanizawa, A Hakura Detection of high-risk human papillomavirus in the cervix and semen of sex partners J Infect Dis 170 1994 682 685
96. M Inoue, A Nakazawa, M Fujita, O Tanizawa Human papillomavirus (HPV) type 16 in semen of partners of women with HPV infection Lancet 339 1992 1114 1115
97. J Green, E Monteiro, VN Bolton, P Sanders, PE Gibson Detection of human papillomavirus DNA by PCR in semen from patients with and without penile warts Genitourin Med 67 1991 207 210
98. P Nieminen, AI Koskimies, J Paavonen Human papillomavirus DNA is not transmitted by semen Int J STD AIDS 2 1991 207 208
99. MA Rintala, PP Pollanen, VP Nikkanen, SE Grenman, SM Syrjanen Human papillomavirus DNA is found in the vas deferens J Infect Dis 185 2002 1664 1667
100. A Kataoka, U Claesson, BG Hansson, M Eriksson, E Lindh Human papillomavirus infection of the male diagnosed by Southern-blot hybridization and polymerase chain reaction: comparison between urethra samples and penile biopsy samples J Med Virol 33 1991 159 164
101. FX Bosch, X Castellsague, N Munoz Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain J Natl Cancer Inst 88 1996 1060 1067
102. A Wikstrom, C Popescu, O Forslund Asymptomatic penile HPV infection: a prospective study Int J STD AIDS 11 2000 80 84
103. S Franceschi, X Castellsague, L Dal Maso Prevalence and determinants of human papillomavirus genital infection in men Br J Cancer 86 2002 705 711
104. EI Svare, SK Kjaer, AM Worm, A Osterlind, CJ Meijer, AJ van den Brule Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic Sex Transm Infect 78 2002 215 218
105. SB Baldwin, DR Wallace, MR Papenfuss Human papillomavirus infection in men attending a sexually transmitted disease clinic J Infect Dis 187 2003 1064 1070
106. HR Shin, S Franceschi, S Vaccarella Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea J Infect Dis 190 2004 468 476
107. SK Kjaer, C Munk, JF Winther, HO Jorgensen, CJ Meijer, AJ van den Brule Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers Cancer Epidemiol Biomarkers Prev 14 2005 1528 1533
108. M Lajous, N Mueller, A Cruz-Valdez Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men Cancer Epidemiol Biomarkers Prev 14 2005 1710 1716
109. GJ Van Doornum, M Prins, LH Juffermans Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study Genitourin Med 70 1994 240 246
110. LA Baken, LA Koutsky, J Kuypers Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance J Infect Dis 171 1995 429 432
111. MC Bleeker, CJ Hogewoning, J Berkhof Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads Clin Infect Dis 41 2005 612 620
112. X Castellsague, A Ghaffari, RW Daniel, FX Bosch, N Munoz, KV Shah Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia J Infect Dis 176 1997 353 361
113. T Iftner, LL Villa Human papillomavirus technologies J Natl Cancer Inst Monogr 31 2003 80 88
114. L Wideroff, MH Schiffman, B Nonnenmacher Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia J Infect Dis 172 1995 1425 1430
115. B Nonnenmacher, S Kruger Kjaer, EI Svare Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations Int J Cancer 68 1996 704 709
116. KM Stone, KL Karem, MR Sternberg Seroprevalence of human papillomavirus type 16 infection in the United States J Infect Dis 186 2002 1396 1402
117. PE Castle, T Shields, R Kirnbauer Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity Sex Transm Dis 29 2002 182 187
118. EI Svare, SK Kjaer, B Nonnenmacher Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women J Infect Dis 176 1997 876 883
119. J Slavinsky 3rd, P Kissinger, L Burger, A Boley, RP DiCarlo, ME Hagensee Seroepidemiology of low and high oncogenic risk types of human papillomavirus in a predominantly male cohort of STD clinic patients Int J STD AIDS 12 2001 516 523
120. DL Thompson, JM Douglas Jr, M Foster Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States J Infect Dis 190 2004 1563 1574
121. EI Grussendorf-Conen, W Meinhof, EM de Villiers, L Gissmann Occurrence of HPV genomes in penile smears of healthy men Arch Dermatol Res 279 suppl 1987 S73 S75
122. SB Baldwin, DR Wallace, MR Papenfuss, M Abrahamsen, LC Vaught, AR Giuliano Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic Sex Transm Dis 31 2004 601 607
123. X Castellsague, FX Bosch, N Munoz Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners N Engl J Med 346 2002 1105 1112
124. EM van der Snoek, HG Niesters, PG Mulder, GJ van Doornum, AD Osterhaus, WI van der Meijden Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study Sex Transm Dis 30 2003 639 644
125. JM Palefsky, EA Holly, ML Ralston, N Jay Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men J Infect Dis 177 1998 361 367
126. JM Palefsky, EA Holly Immunosuppression and co-infection with HIV J Natl Cancer Inst Monogr 31 2003 41 46
127. CW Critchlow, CM Surawicz, KK Holmes Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection AIDS 9 1995 1255 1262
128. PL Breese, FN Judson, KA Penley, JM Douglas Jr Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus Sex Transm Dis 22 1995 7 14
129. CW Critchlow, SE Hawes, JM Kuypers Effect of HIV infection on the natural history of anal human papillomavirus infection AIDS 12 1998 1177 1184
130. BJ Klencke, JM Palefsky Anal cancer: an HIV-associated cancer Hematol Oncol Clin North Am 17 2003 859 872
131. S Goldstone Anal dysplasia in men who have sex with men AIDS Read 9 1999 204 208 220
132. D Serraino, L Dal Maso, C La Vecchia, S Franceschi Invasive cervical cancer as an AIDS-defining illness in Europe AIDS 16 2002 781 786
133. EJ Fordyce, Z Wang, AR Kahn Risk of cancer among women with AIDS in New York City AIDS Public Policy J 15 2000 95 104
134. S de Sanjose, J Palefsky Cervical and anal HPV infections in HIV positive women and men Virus Res 89 2002 201 211
135. JJ Goedert, TR Cote, P Virgo Spectrum of AIDS-associated malignant disorders Lancet 351 1998 1833 1839
136. M Frisch, RJ Biggar, EA Engels, JJ Goedert Association of cancer with AIDS-related immunosuppression in adults JAMA 285 2001 1736 1745
137. JM Palefsky, EA Holly, ML Ralston Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection J Acquir Immune Defic Syndr 28 2001 422 428
138. C Piketty, TM Darragh, I Heard High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy Sex Transm Dis 31 2004 96 99
139. RW Blum Uganda AIDS prevention: A,B,C and politics J Adolesc Health 34 2004 428 432
140. RL Stoneburner, D Low-Beer Sexual partner reductions explain human immunodeficiency virus declines in Uganda: comparative analyses of HIV and behavioural data in Uganda, Kenya, Malawi, and Zambia Int J Epidemiol 33 2004 624
141. RL Stoneburner, D Low-Beer Population-level HIV declines and behavioral risk avoidance in Uganda Science 304 2004 714 718
142. LM Wen, CS Estcourt, JM Simpson, A Mindel Risk factors for the acquisition of genital warts: are condoms protective? Sex Transm Infect 75 1999 312 316
143. MC Bleeker, CJ Hogewoning, FJ Voorhorst Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia Int J Cancer 107 2003 804 810
144. LF Zhang, J Zhou, S Chen HPV6b virus like particles are potent immunogens without adjuvant in man Vaccine 18 2000 1051 1058
145. CD Harro, YY Pang, RB Roden Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine J Natl Cancer Inst 93 2001 284 292
146. TG Evans, W Bonnez, RC Rose A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers J Infect Dis 183 2001 1485 1493
147. DR Brown, JT Bryan, JM Schroeder Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer J Infect Dis 184 2001 1183 1186
148. RT Emeny, CM Wheeler, KU Jansen Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine J Virol 76 2002 7832 7842
149. DA Galloway Papillomavirus vaccines in clinical trials Lancet Infect Dis 3 2003 469 475
150. Nolan T, Block SL, Reisinger KS, et al. Comparison of the immunogenicity and tolerability of a prophylactic quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine in male and female adolescents and young adult women. 23rd Annual Meeting of the European Society for Paediatric Infectious Disease; Valencia, Spain; May 18-20, 2005. Abstract 236. http://www.kenes.com/espid2005/program/CopyFile.asp?FileName=236.doc (accessed Nov 23, 2005).
151. JP Hughes, GP Garnett, L Koutsky The theoretical population-level impact of a prophylactic human papilloma virus vaccine Epidemiology 13 2002 631 639